This Article Full Text Full Text (PDF) All Versions of this Article: 42/2/123    most recent 01.HYP.0000083340.57063.35v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lavery, G. G. Articles by Stewart, P. M. Search for Related Content PubMed PubMed Citation Articles by Lavery, G. G. Articles by Stewart, P. M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information High Blood Pressure Related Collections Other hypertension Hypertension - basic studies Other etiology Genetics of cardiovascular disease

(Hypertension. 2003;42:123.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Late-Onset Apparent Mineralocorticoid Excess Caused by Novel Compound Heterozygous Mutations in the HSD11B2 Gene

Gareth G. Lavery; Vanessa Ronconi; Nicole Draper; Elizabeth H. Rabbitt; Val Lyons; Karen E. Chapman; Elizabeth A. Walker; Claire L. McTernan; Gilberta Giacchetti; Franco Mantero; Jonathan R. Seckl; Christopher R.W. Edwards; John M.C. Connell; Martin Hewison; Paul M. Stewart

From the Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital (G.G.L., N.D., E.H.R., E.A.W., C.L.M., M.H., P.M.S.), Edgbaston, Birmingham, UK; the Division of Endocrinology, Department of Internal Medicine, University of Ancona (V.R., G.G.), Italy; Molecular Medicine, University of Edinburgh, Western General Hospital (V.L., K.E.C., J.R.S.), Edinburgh, UK; the Department of Medical and Surgical Sciences, University of Padova (F.M.), Italy; the Vice-Chancellor’s Office, University of Newcastle-Upon-Tyne (C.R.W.E.), Newcastle-Upon-Tyne, UK; and the MRC Blood Pressure Group, Western Infirmary (J.M.C.C.), Glasgow, UK.

Correspondence to Prof Paul M. Stewart, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH. E-mail p.m.stewart{at}bham.ac.uk

Mutations in the gene encoding 11ß-hydroxysteroid dehydrogenase type 2, 11ß-HSD2 (HSD11B2), explain the molecular basis for the syndrome of apparent mineralocorticoid excess (AME), characterized by severe hypertension and hypokalemic alkalosis. Cortisol is the offending mineralocorticoid in AME, as the result of a lack of 11ß-HSD2–mediated cortisol to cortisone inactivation. In this study, we describe mutations in the HSD11B2 gene in 3 additional AME kindreds in which probands presented in adult life, with milder phenotypes including the original seminal case reported by Stewart and Edwards. Genetic analysis of the HSD11B2 gene revealed that all probands were compound heterozygotes, for a total of 7 novel coding and noncoding mutations. Of the 7 mutations detected, 6 were investigated for their effects on gene expression and enzyme activity by the use of mutant cDNA and minigene constructs transfected into HEK 293 cells. Four missense mutations resulted in enzymes with varying degrees of activity, all <10% of wild type. A further 2 mutations generated incorrectly spliced mRNA and predicted severely truncated, inactive enzyme. The mothers of 2 probands heterozygous for missense mutations have presented with a phenotype indistinguishable from "essential" hypertension. These genetic and biochemical data emphasize the heterogeneous nature of AME and the effects that heterozygosity at the HSD11B2 locus can have on blood pressure in later life.

Key Words: hypertension, genetic • hypertension, essential • mutation • mineralocorticoids • genes

This article has been cited by other articles:

				G. Morineau, V. Sulmont, R. Salomon, B. Fiquet-Kempf, X. Jeunemaitre, J. Nicod, and P. Ferrari Apparent Mineralocorticoid Excess: Report of Six New Cases and Extensive Personal Experience J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3176 - 3184. [Abstract] [Full Text] [PDF]

				N. Draper and P. M Stewart 11{beta}-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action J. Endocrinol., August 1, 2005; 186(2): 251 - 271. [Abstract] [Full Text] [PDF]

				P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF]

				K. Lin-Su, P. Zhou, N. Arora, B. P. Betensky, M. I. New, and R. C. Wilson In Vitro Expression Studies of a Novel Mutation {Delta}299 in a Patient Affected with Apparent Mineralocorticoid Excess J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2024 - 2027. [Abstract] [Full Text] [PDF]